BaroFold

company

About

BaroFold is a biopharmaceutical company focused on the development of protein therapeutics for immunology indications.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$2.50M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
1 - 10
Operating Status
Active

BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company's goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMTâ„¢ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$14.50M
BaroFold has raised a total of $14.50M in funding over 2 rounds. Their latest funding was raised on May 29, 2007 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 29, 2007 Series A $12M 1 Detail
Mar 1, 2006 Series Unknown $2.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
BaroFold is funded by 1 investors. The Peierls Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
The Peierls Foundation Series A